Syndax Pharmaceuticals, Inc. (SNDX)
24.64
+0.35
(+1.44%)
USD |
NASDAQ |
Apr 07, 16:00
24.98
+0.34
(+1.38%)
Pre-Market: 08:27
Syndax Pharmaceuticals Total Liabilities (Quarterly) : 465.08M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 301.24M |
| Vera Therapeutics, Inc. | 130.78M |
| Biogen, Inc. | 11.18B |
| Johnson & Johnson | 117.67B |
| Tango Therapeutics, Inc. | 63.83M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 529.71M |
| Shareholders Equity (Quarterly) | 64.63M |
| Debt to Equity Ratio | 5.345 |
| Current Ratio | 4.396 |
| Net Debt Paydown Yield | -3.75% |